Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report

Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report

Chunlan Fu,1 Yuanyuan Zhu,2 Weijia Huang,2 Yi Luo,2 Yongxian Hu,2 He Huang,2 Jie Sun2 1Department of Hematology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, Zhejiang, 311800, People’s Republic of China; 2Transplantation Center, The First Affiliated Hospital, Zhejiang University S...

Full description

Bibliographic Details
Main Authors: Fu C, Zhu Y, Huang W, Luo Y, Hu Y, Huang H, Sun J
Format: Article
Language:English
Published: Dove Medical Press 2024-01-01
Series:Infection and Drug Resistance
Subjects:
covid-19
hematologic malignancy
tocilizumab
Online Access:https://www.dovepress.com/using-tocilizumab-in-hematologic-malignant-patients-with-severe-covid--peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/using-tocilizumab-in-hematologic-malignant-patients-with-severe-covid--peer-reviewed-fulltext-article-IDR

Similar Items